NCT06732388 2026-03-18
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
National Cancer Institute (NCI)
Phase 2 Not yet recruiting
Clinical Trials
94 trialsNCT02558504 2025-10-02
HARMONI
Hospices Civils de Lyon
Phase 4 Completed
NCT01792934 2025-04-15
ORCHESTRA
Radboud University Medical Center
Phase NA Active not recruiting
NCT04062721 2025-04-06
LICoRN-01
Assistance Publique - Hôpitaux de Paris
Phase 1 Not yet recruiting
NCT05551299 2025-03-27
CARP
University of Leipzig
Phase 4 Recruiting
NCT06038552 2025-02-26
Comparison of Clinical Efficacy of Liver Resection, RFA, TACE, and Drug Therapy in Patients with GIST LM
First Affiliated Hospital, Sun Yat-Sen University
Completed
NCT04798898 2024-12-05
ISCOLIM
University of Aarhus
Phase NA Recruiting
NCT06682377 2024-11-12
SM-OCT-01
Seoul National University Hospital
Phase NA Active not recruiting
NCT06609434 2024-09-27
The Role and Safety of Radiofrequency Ablation in Recurrent Liver Metastasis of Colorectal Cancer
Peking University Cancer Hospital & Institute
Phase NA Not yet recruiting
NCT03753659 2024-07-22
IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Completed
NCT04047173 2024-06-17
RFA Versus SBRT for Recurrent Small HCC
Sun Yat-sen University
Phase 3 Completed
NCT02146508 2023-12-11
EXPECT
Tenwek Hospital
Phase NA Suspended
NCT02688114 2023-09-11
Healing of the Esophageal Mucosa After RFA of Barrett's Esophagus
Dallas VA Medical Center
Phase NA Completed
NCT04555265 2023-08-31
Cytokine Change in Hepatocellular Carcinoma Treated by Thermal Ablation
Chinese University of Hong Kong
Phase NA Completed
NCT05433701 2023-08-18
Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCC
Asan Medical Center
Phase NA Active not recruiting
NCT05233293 2023-08-15
Spyglass+RFA Versus Cytobrush+RFA for Extrahepatic Cholangiocarcinoma
First People's Hospital of Hangzhou
Phase NA Unknown
NCT00813293 2023-06-13
Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
Beth Israel Deaconess Medical Center
Phase 2 Completed
NCT05243082 2023-03-30
ERFA-PNET
Oslo University Hospital
Phase NA Recruiting
NCT02821754 2023-03-28
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT03183115 2023-03-03
RFA to Prevent Metachronous Squamous Neoplasia Recurrence After Complete Endoscopic Submucosal Dissection
E-DA Hospital
Phase NA Recruiting
NCT05028439 2023-02-21
RFA Combined With Chemotherapy for Unresectable Cholangiocarcinoma
First People's Hospital of Hangzhou
Phase NA Completed
NCT05666271 2022-12-27
Radiofrequency Ablation for Hepatocellular Carcinoma Using Octopus MP Electrodes
Seoul National University Hospital
Unknown
NCT03088150 2022-12-20
COLLISION
Amsterdam UMC, location VUmc
Phase NA Unknown
NCT05257694 2022-10-21
Clinical Decision Biological Biomarker and Prognosis Prediction of Hepatocellular Carcinoma by Deep Learning
Chinese PLA General Hospital
Unknown
NCT03362749 2022-10-14
EAST
National Taiwan University Hospital
Unknown
NCT05580224 2022-10-14
Anatomical Radiofrequency Ablation for Small Hepatocellular Carcinoma
Seoul National University Hospital
Phase NA Unknown
NCT04574245 2022-10-05
RECORD
Chinese PLA General Hospital
Unknown
NCT05485909 2022-08-03
Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM
Sun Yat-sen University
Phase 2 Unknown
NCT02243384 2022-06-02
Laparoscopic Hepatectomy and Radiofrequency Ablation in the Treatment of Early Hepatocellular Carcinoma
Southwest Hospital, China
Phase NA Completed
NCT03101475 2022-05-31
ILOC
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT05320328 2022-04-11
MBOP
Asian Institute of Gastroenterology, India
Unknown
NCT01340105 2022-03-21
Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation
Chinese University of Hong Kong
Phase NA Completed
NCT05162898 2022-01-27
Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma.
Henan Cancer Hospital
Phase NA Unknown
NCT02192671 2022-01-18
HR-HCC/PHT
Guangxi Medical University
Phase 3 Unknown
NCT01961778 2022-01-12
Comparison of Treatments for Barrett's Esophagus With High-Grade Dysplasia/Early Adenocarcinoma
Massachusetts General Hospital
Phase NA Completed
NCT04301999 2021-09-01
Clinical Effect and Safety of PDT and RFA for Unresectable EHCC
First People's Hospital of Hangzhou
Phase NA Completed
NCT03621319 2021-07-06
BURN
Erbe Elektromedizin GmbH
Phase NA Terminated
NCT02973204 2021-04-28
Circulating Tumor Cells and Tumor DNA in HCC and NET
University of Aarhus
Completed
NCT04707547 2021-01-13
RFA
Taipei Medical University WanFang Hospital
Phase 4 Completed
NCT03898921 2020-11-24
RFA vs. SBRT for Small HCC
Sun Yat-sen University
Phase 3 Unknown
NCT02340728 2020-10-22
Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic Malignancies
Memorial Sloan Kettering Cancer Center
Phase 3 Completed
NCT01844245 2020-10-14
Endobiliary RFA for Unresectable Malignant Biliary Strictures
Eastern Hepatobiliary Surgery Hospital
Phase NA Completed
NCT04553458 2020-09-17
Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma
Sohag University
Completed
NCT00132041 2020-09-10
ACRIN-6673
American College of Radiology Imaging Network
Phase NA Completed
NCT02953418 2020-08-12
REACH
Medtronic - MITG
Phase NA Terminated
NCT02169765 2020-07-22
ARTC-HCC
Guangxi Medical University
Phase 3 Unknown
NCT04150744 2020-07-08
RFA Plus Carrizumab vs Carrizumab Alone for HCC
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
NCT04417010 2020-06-09
To Identify KRAS Gene and Safe Margin in Association With Outcome in Colorectal Liver Metastases Following Ultrasound-guided Radiofrequency Ablation
Peking University Cancer Hospital & Institute
Unknown
NCT02047305 2020-05-21
Radiofrequency Ablation for Patients With Esophageal Squamous Cell Neoplasia
Medtronic - MITG
Phase NA Completed
NCT01486134 2020-05-13
ARMTICH
Assistance Publique - Hôpitaux de Paris
Phase NA Terminated